ICBC warns teens for prom
44-year-old woman missing
Stanley Cup Playoff etiquette
Senators reject field trip
'City within a city'
Searching landfill for woman
Israeli strike played down
Full Trump jury seated
World's largest election 
Lululemon cuts 100 jobs
Bitcoin's 'halving' arrives
Lawsuit over missing nuts
Warriors ready for Round 2
Kalamalka Bowl cancelled
Rockets live to fight on
Pulp Fiction turns 30
Chris Pratt injured in movie
My name is not Elaine
Photo: The Canadian Press
Public Services and Procurement Minister Filomena Tassi rises during Question Period, in Ottawa, Friday, Dec. 3, 2021. Tassi says Canada has signed agreements to buy up 1.5 million courses of oral antiviral treatment for COVID-19. THE CANADIAN PRESS/Adrian Wyld
Procurement Minister Filomena Tassi says Canada has signed agreements to buy up 1.5 million courses of oral antiviral treatment for COVID-19.
The government has signed up for an initial one million courses of antiviral treatment, once Health Canada endorses their safety and efficacy.
Pfizer submitted a request for Health Canada approval earlier this week.
Canada has also purchased 500,000 courses of Merck's oral antiviral treatment for COVID-19, with the option to purchase another 500,000 once Health Canada approves the drug.
The drugs are designed to block the enzyme essential for viral replication.
Merck's clinical trial showed a 50 per cent reduced risk of hospitalization or death compared to placebo patients with mild or moderate COVID-19.
